Ractigen Therapeutics begins patient dosing in phase I trial of RAG-17 in SOD1-ALS: Nantong, China Friday, December 27, 2024, 12:00 Hrs [IST] Ractigen Therapeutics, a clinical-sta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback